Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > NOX Investor Relations

<< Previous

Bullboard Posts

Next >>

Comment by MrMonkon Oct 30, 2013 9:19pm

197 Views

Post# 21863888

RE:RE:NOX Investor Relations

Watching the share price slide to levels we previously thought unimaginable is downright painful. I've recommended this stock to some family members who bought in the 20's and even 30's and I feel like garbage right now. Company has cash and a good resource which will keep it solvent. It's difficult to get hurt at these levels, however I said the same thing at 20 cents. I can't see the bottom being lower than where we are today though.

Longs are going to have to be long longer than we had planned for. This is an excellent lesson in only investing capital to which access will not be needed for awhile.

- MM

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario